These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 6177768)

  • 41. Mouse lymph node germinal centers contain a selected subset of T cells--the helper phenotype.
    Rouse RV; Ledbetter JA; Weissman IL
    J Immunol; 1982 May; 128(5):2243-6. PubMed ID: 6120978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of B lymphocyte proliferation by monoclonal anti-Lyb 2 antibody.
    Subbarao B; Mosier DE
    J Immunol; 1983 May; 130(5):2033-7. PubMed ID: 6601145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice.
    Wither JE; Roy V; Brennan LA
    Clin Immunol; 2000 Jan; 94(1):51-63. PubMed ID: 10607490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ly-2+ T cell enlargement and null cell proliferation occur at the onset of splenomegaly and autoantibody production in New Zealand Black mice.
    Manohar V; Brown EM; Leiserson WM; Edison LJ; Chused TM
    J Immunol; 1984 Dec; 133(6):3020-5. PubMed ID: 6333451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1.
    Hogarth PM; Potter TA; Cornell FN; McLachlan R; McKenzie IF
    J Immunol; 1980 Oct; 125(4):1618-24. PubMed ID: 6997382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.
    Descamps-Latscha B; Golub RM; Nguyen AT; Feuillet-Fieux MN
    J Immunol; 1983 Nov; 131(5):2500-7. PubMed ID: 6195264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
    Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
    J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of a fetal calf serum-induced T cell line. I. H-2 restricted growth and expression of membrane-bound and released molecules bearing 5936-idiotypic determinants.
    Suzan M; Bourgois A; Boned A; De Preval C; Golstein P; Rubin B
    J Immunol; 1981 Sep; 127(3):992-9. PubMed ID: 6167637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Murine intestinal intraepithelial lymphocytes I. Relationship of a novel Thy-1-,Lyt-1-,Lyt-2+, granulated subpopulation to natural killer cells and mast cells.
    Petit A; Ernst PB; Befus AD; Clark DA; Rosenthal KL; Ishizaka T; Bienenstock J
    Eur J Immunol; 1985 Mar; 15(3):211-5. PubMed ID: 2858391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T helper cells in immune mice amplify the primary anti-tumor cytotoxic response.
    Yu AS; Bernstein ID
    J Immunol; 1982 Aug; 129(2):856-9. PubMed ID: 6177788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of the Fc gamma receptor on Ly-1+ B lymphocytes.
    Dexter CM; Corley RB
    Eur J Immunol; 1987 Jun; 17(6):867-71. PubMed ID: 2954830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The ontogeny and distribution of B cells in normal and mutant immune-defective CBA/N mice: two-parameter analysis of surface IgM and IgD.
    Scher I; Titus JA; Finkelman FD
    J Immunol; 1983 Feb; 130(2):619-25. PubMed ID: 6600246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
    Guerne PA; Piguet PF; Vassalli P
    J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
    Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
    J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ly 9, an alloantigenic marker of lymphocyte differentiation.
    Mathieson BJ; Sharrow SO; Bottomly K; Fowlkes BJ
    J Immunol; 1980 Nov; 125(5):2127-36. PubMed ID: 7000897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered CD45 expression in malignant B-1 cells.
    Dang AM; Phillips JA; Lin T; Raveche ES
    Cell Immunol; 1996 May; 169(2):196-207. PubMed ID: 8620547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth and differentiation in vitro of the accumulating Lyt-2-/L3T4- subset in lpr mice.
    Budd RC; MacDonald HR; Lowenthal JW; Davignon JL; Izui S; Cerottini JC
    J Immunol; 1985 Dec; 135(6):3704-11. PubMed ID: 3934265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of Ly-6.2-bearing murine lymphocyte subpopulations in relation to the T-lymphocyte markers, Thy-1, Lyt-1, and Lyt-2.
    Matossian-Rogers A; Rogers P; Herzenberg LA
    Cell Immunol; 1982 May; 69(1):91-100. PubMed ID: 7049403
    [No Abstract]   [Full Text] [Related]  

  • 59. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.
    Sarmiento M; Glasebrook AL; Fitch FW
    J Immunol; 1980 Dec; 125(6):2665-72. PubMed ID: 6159417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice.
    Muul LM; Scher I; Mond JJ; Finkelman FD
    J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.